...
首页> 外文期刊>Biosensors >Non-Invasive Diagnosis of Diabetes by Volatile Organic Compounds in Urine Using FAIMS and Fox4000 Electronic Nose
【24h】

Non-Invasive Diagnosis of Diabetes by Volatile Organic Compounds in Urine Using FAIMS and Fox4000 Electronic Nose

机译:利用FAIMS和Fox4000电子鼻对尿液中的挥发性有机物进行非侵入性诊断

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The electronic nose (eNose) is an instrument designed to mimic the human olfactory system. Usage of eNose in medical applications is more popular than ever, due to its low costs and non-invasive nature. The eNose sniffs the gases and vapours that emanate from human waste (urine, breath, and stool) for the diagnosis of variety of diseases. Diabetes mellitus type 2 (DM2) affects 8.3% of adults in the world, with 43% being underdiagnosed, resulting in 4.9 million deaths per year. In this study, we investigated the potential of urinary volatile organic compounds (VOCs) as novel non-invasive diagnostic biomarker for diabetes. In addition, we investigated the influence of sample age on the diagnostic accuracy of urinary VOCs. We analysed 140 urine samples (73 DM2, 67 healthy) with Field-Asymmetric Ion Mobility Spectrometry (FAIMS); a type of eNose; and FOX 4000 (AlphaM.O.S, Toulouse, France). Urine samples were collected at UHCW NHS Trust clinics over 4 years and stored at ?80 °C within two hours of collection. Four different classifiers were used for classification, specifically Sparse Logistic Regression, Random Forest, Gaussian Process, and Support Vector on both FAIMS and FOX4000. Both eNoses showed their capability of diagnosing DM2 from controls and the effect of sample age on the discrimination. FAIMS samples were analysed for all samples aged 0–4 years (AUC: 88%, sensitivity: 87%, specificity: 82%) and then sub group samples aged less than a year (AUC (Area Under the Curve): 94%, Sensitivity: 92%, specificity: 100%). FOX4000 samples were analysed for all samples aged 0–4 years (AUC: 85%, sensitivity: 77%, specificity: 85%) and a sub group samples aged less than 18 months: (AUC: 94%, sensitivity: 90%, specificity: 89%). We demonstrated that FAIMS and FOX 4000 eNoses can discriminate DM2 from controls using urinary VOCs. In addition, we showed that urine sample age affects discriminative accuracy.
机译:电子鼻(eNose)是一种模仿人类嗅觉系统的仪器。由于其低成本和无创性,在医学应用中使用eNose比以往更受欢迎。 eNose嗅探人类废物(尿液,呼吸和粪便)中散发的气体和蒸气,以诊断各种疾病。 2型糖尿病(DM2)影响世界上8.3%的成年人,其中43%的人被误诊,每年导致490万人死亡。在这项研究中,我们调查了尿挥发性有机化合物(VOCs)作为糖尿病的新型非侵入性诊断生物标志物的潜力。此外,我们调查了样本年龄对尿中挥发性有机化合物诊断准确性的影响。我们使用场不对称离子迁移谱仪(FAIMS)分析了140个尿液样本(73个DM2,67个健康);一种eNose;和FOX 4000(法国图卢兹的AlphaM.O.S)。在UHCW NHS Trust诊所收集了4年以上的尿液样本,并在收集后的两个小时内将其保存在80°C下。四个不同的分类器用于分类,特别是在FAIMS和FOX4000上的稀疏逻辑回归,随机森林,高斯过程和支持向量。两种eNoses均显示了它们从对照诊断DM2的能力以及样品年龄对区分度的影响。对于所有0–4岁的样本(AUC:88%,敏感性:87%,特异性:82%)然后对年龄小于一年的亚组样本(AUC(曲线下面积):94%,FAIMS样本进行了分析,灵敏度:92%,特异性:100%)。对所有0–4岁(AUC:85%,灵敏度:77%,特异性:85%)和年龄小于18个月的亚组样品(AUC:94%,灵敏度:90%,特异性:89%)。我们证明了FAIMS和FOX 4000 eNoses可以将DM2与使用尿液VOC的对照区分开。此外,我们表明尿液样本年龄会影响判别准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号